Development of a Prospective and Monocentric Cinical and Biological Database in Epithelial Ovarian Cancer, Fallopian Tube Cancer and Primitive Peritoneal Cancer
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 300
- Locations
- 2
- Primary Endpoint
- Proportion of patients who gave their consent to participate in the study
Study Overview
Brief Summary
A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical datas to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to epithetial ovarian cancer, Fallopian tube cancer and Primitive peritoneal cancer.
Detailed Description
A Clinical and Biological Database is a collection of reliable, prospective and representative datas.
This collection, provided to the scientific community, will help to develope research programs such as :
- Cinicals and biological predictive factors of treatments response
- Identification of biological tumoral markers associate with survival
- Identification of prognosic factors after recidivism
- Diagnostics tests optimisation and follow-up from blood samples ( Circulating Tumor Cells (CTC) )
- Developing strong preclinical models. Those models would be later used to test alternative treatments and would help to identify new biomarkers
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •18 or older
- •Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caner or a primitive peritoneal cancer
- •Patient eligible for, at least, one surgery and a chemotherapy
- •Patient having given his informed, written and express consent
Exclusion Criteria
- •Patient not affiliated to a social protection scheme
- •Pregnant and / or nursing women
- •Subject under tutelage, curatorship or safeguard of justice
- •Patient whose regular follow-up is impossible for psychological, familial, social or geographical reasons
Outcomes
Primary Outcomes
Proportion of patients who gave their consent to participate in the study
Time Frame: Until the study completion : 3 years
The proportion of patients who consent to participate in the study among the screened patients
Secondary Outcomes
No secondary outcomes reported